Biochemical and biophysical characterization of the main protease, 3-chymotrypsin-like protease (3CLpro) from the novel coronavirus SARS-CoV 2

Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) is responsible for the novel coronavirus disease 2019 (COVID-19). An appealing antiviral drug target is the coronavirus 3C-like protease (3CLpro) that is responsible for the processing of the viral polyproteins and liberation of functional...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferreira, Juliana C., Rabeh, Wael M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747600/
https://www.ncbi.nlm.nih.gov/pubmed/33335206
http://dx.doi.org/10.1038/s41598-020-79357-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747600/
https://www.ncbi.nlm.nih.gov/pubmed/33335206
http://dx.doi.org/10.1038/s41598-020-79357-0

Ejemplares similares